QUality Of Life and surviVAl in carDIac arreSt Patients

NCT ID: NCT04129073

Last Updated: 2022-03-16

Basic Information

• Recruitment Status: NOT_YET_RECRUITING
• Total Enrollment: 1600 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2022-12-01
• Study Completion Date: 2026-11-30

Brief Summary

QUO VADIS is a national observational study with the aim to describe clinical intervention and utilization of neuroprognostication tools in the management of patients admitted to ICU following cardiac arrest

Detailed Description

Despite recent improvements in post-resuscitation care, about 50% of patients resuscitated from cardiac arrest die or have poor neurological prognosis. Post-anoxic brain injury is common after cardiac arrest and is a major cause of post-resuscitation mortality. Since there has been a significant investment in improving the emergency response to both in-hospital ad out-of-hospital cardiac arrest (IHCA and OHCA, respectevly) patients and reported improvements in short-term survival outcomes, the long-term neurological state and quality of life of survivors and their caregiver is of growing significance.

QUO VADIS is a national observational study created to describe clinical interventions and utilization of neuroprognostication tools in the management of patients admitted to ICU following cardiac arrest.

The aims of the study are:

• To create an Italian Registry that describes clinical interventions and neuroprognostication tools used in the management of patients admitted to ICU following cardiac arrest
• To evaluate, after one year from the cardiac arrest, the neurological outcome and the quality of life of the patients;
• To evaluate, after one year from the cardiac arrest, the quality of life of caregivers;
• To identify the most effective clinical intervention in the management of post-cardiac arrest patients admitted to ICU;
• To create a prognostic model for patients admitted to ICU after cardiac arrest.

Conditions

Cardiac Arrest; Post-Anoxic Coma; Central Nervous System Diseases

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

Cardiac arrest patients admitted to Intensive Care treatment

Intensive Care treatment; Utilization of neuroprognostication tools

Intensive care treatment

Intervention Type: OTHER

Intensive care treatment; Utilization of neuroprognostication tools

Interventions

Intensive care treatment

Intensive care treatment; Utilization of neuroprognostication tools

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Age ≥ 14 years;
• Cardiac Arrest within 24 hours ICU admission

Exclusion Criteria

• Absence of Informed consent;
• Age < 14 years

• Minimum Eligible Age: 14 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Sergio Livigni, MD

Role: PRINCIPAL_INVESTIGATOR

Ospedale San Giovanni Bosco, Turin

Central Contacts

Elena Garbero, MSc

Role: CONTACT

giviti@marionegri.it

+390354535388

Alice Lavetti

Role: CONTACT

giviti@marionegri.it

+390354535313

Related Links

http://www.giviti.marionegri.it/

GiViTI website

Other Identifiers

QUO VADIS

Identifier Type: -

Identifier Source: org_study_id